Indiana Broadcast History Archive

To access IBHA outside of Indiana University:

 

  1. Create an IU Guest Account here.
  2. Contact IBHA Archivist with the items/collections requested.
  3. Once you have been given access, login to the items requested with your IU Guest Account credentials.

Click here for more information on our access policies

Need more help? Contact IBHA Archivist

CAS Sign In

[AI-Generated Summary] While the FDA and supporters consider the five-year contraceptive Norplant to be an extremely safe and effective birth control method, it faces a gathering storm of legal challenges as thousands of women report severe health complications, inadequate product warnings, and insufficient physician training. Patients detail agonizing adverse effects ranging from persistent bleeding, severe weight changes, and depression to life-threatening conditions like ectopic pregnancies, brain aneurysms, and strokes. Complicating matters further, many affected women—particularly low-income patients no longer covered by Medicaid—struggle to find doctors willing or trained to perform the painful, complex removal procedure. In response to growing class action lawsuits across states like Texas and Indiana, distributor Wyeth-Ayerst defends the product's safety record alongside positive medical research, while medical experts warn that the surrounding litigation risks chilling future advancements in contraceptive technology.

This AI-generated summary (via Gemini AI and Adobe Premiere Pro) is for discovery purposes only. Please consult the original recording for historical accuracy.